Agios Pharmaceuticals (AGIO) Long-Term Deferred Tax (2012 - 2013)
Agios Pharmaceuticals' (AGIO) quarterly Long-Term Deferred Tax came in at $2.7 million in Q3 2013, little changed on a QoQ basis from $2.7 million in Q2 2013.
Analysis
Agios Pharmaceuticals (AGIO) Long-Term Deferred Tax (2012 - 2013) Analysis & Trends
Agios Pharmaceuticals (AGIO) has 2 years of Long-Term Deferred Tax data on file, last reported at $2.7 million in Q3 2013.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $2.7 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $2.7 million (changed N/A YoY) and the FY2012 annual result came in at $2.7 million, changed N/A from the prior year.
- Long-Term Deferred Tax held at $2.7 million in Q3 2013, from $2.7 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $2.7 million in Q4 2012 to a low of $2.7 million in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Agios Pharmaceuticals | 1.97 Bn | 1.97 Bn | 41.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2013 | 2.71 Mn |
| Jun 30, 2013 | 2.71 Mn |
| Dec 31, 2012 | 2.71 Mn |